Navigation path

Pharmaceuticals - Union Register

  

Register of not active orphan medicinal products


WITHDRAWN  

Product information

Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment from Staphylococcus aureus protein A

EU orphan designation number: EU/3/15/1489
Active ingredient: Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment from Staphylococcus aureus protein A
Indication: Treatment of myasthenia gravis
Sponsor: Toleranzia AB
Arvid Wallgrens backe 20, 8th floor, 413 46 Goteborg, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/05/2015 Orphan designation EMA/OD/318/14 (2015)3569 of 21/05/2015
4/04/2019 Removal of orphan designation from Community Register